Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph J Zech

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|July 29, 2018
Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging studyKwadwo Antwi, Melpomeni Fani, Tobias Heye, et al.
AJR. American Journal of Roentgenology|June 25, 2013
Consensus report of the Fifth International Forum for Liver MRIChristoph J Zech, Carlo Bartolozzi, Paulette Bioulac-Sage, et al.
Plos One|October 17, 2012
Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohortMark op den Winkel, Dorothea Nagel, Julia Sappl, et al.
European Radiology|June 14, 2015
Consensus report from the 7th International Forum for Liver Magnetic Resonance ImagingElmar M Merkle, Christoph J Zech, Carlo Bartolozzi, et al.
Frontiers in Oncology|June 26, 2024
Safety and efficacy of Holmium-166 selective internal radiotherapy of primary and secondary liver cancer confirmed by real-world dataVictor Schulze-Zachau, Gontran Verset, Pieter De Bondt, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic CohortMax Seidensticker, Ingo G Steffen, Irene Bargellini, et al.
JHEP Reports : Innovation in Hepatology|October 26, 2020
Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinomaJens Ricke, Ingo G Steffen, Irene Bargellini, et al.
British Journal of Cancer|October 23, 2021
Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinomaOsman Öcal, Michael Ingrisch, Muzaffer Reha Ümütlü, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 5, 2022
Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenibOsman Öcal, Regina Schinner, Kerstin Schütte, et al.
European Radiology|July 26, 2022
Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progressionOsman Öcal, Christoph J Zech, Matthias P Fabritius, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
European Journal of Nuclear Medicine and Molecular Imaging|July 29, 2018
Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging studyKwadwo Antwi, Melpomeni Fani, Tobias Heye, et al.
AJR. American Journal of Roentgenology|June 25, 2013
Consensus report of the Fifth International Forum for Liver MRIChristoph J Zech, Carlo Bartolozzi, Paulette Bioulac-Sage, et al.
Plos One|October 17, 2012
Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohortMark op den Winkel, Dorothea Nagel, Julia Sappl, et al.
European Radiology|June 14, 2015
Consensus report from the 7th International Forum for Liver Magnetic Resonance ImagingElmar M Merkle, Christoph J Zech, Carlo Bartolozzi, et al.
Frontiers in Oncology|June 26, 2024
Safety and efficacy of Holmium-166 selective internal radiotherapy of primary and secondary liver cancer confirmed by real-world dataVictor Schulze-Zachau, Gontran Verset, Pieter De Bondt, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic CohortMax Seidensticker, Ingo G Steffen, Irene Bargellini, et al.
JHEP Reports : Innovation in Hepatology|October 26, 2020
Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinomaJens Ricke, Ingo G Steffen, Irene Bargellini, et al.
British Journal of Cancer|October 23, 2021
Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinomaOsman Öcal, Michael Ingrisch, Muzaffer Reha Ümütlü, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 5, 2022
Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenibOsman Öcal, Regina Schinner, Kerstin Schütte, et al.
European Radiology|July 26, 2022
Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progressionOsman Öcal, Christoph J Zech, Matthias P Fabritius, et al.
Pageof 8